Drug
Levalbuterol clinical trials
Also written Xopenex and levosalbutamol.
Keep track of what changes. Save the Levalbuterol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Asthma
- 10
Who runs them
Industry 12 · Other 9
Sumitomo Pharma America, Inc. (7) · Neutec Ar-Ge San ve Tic A.Ş (2) · University of Dundee (2) · Astion Pharma A/S (2) · Phoenix Children's Hospital (1) · Children's Hospital Los Angeles (1) · University of Illinois at Chicago (1) · Fahim Khorfan, MD (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Levalbuterol is read from its arms, and is right about nine times in ten.
Testing it · 21
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsRecruitingPhase 3Neutec Ar-Ge San ve Tic A.ŞNCT05890638Written as Ipratropium / Levosalbutamol Fixed Dose Combination
- Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)CompletedPhase 4Phoenix Children's HospitalNCT00585039Written as xopenex
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsActive, not recruitingPhase 3Neutec Ar-Ge San ve Tic A.ŞNCT06040424Written as Ipratropium / Levosalbutamol Fixed Dose Combination
- Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Sumitomo Pharma America, Inc.NCT00665600Written as Levalbuterol HCl
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.Status unknownPhase 4University of AleppoNCT05173584Written as Levalbuterol
- Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy AdultsCompletedNot applicableChildren's Hospital Los AngelesNCT02802111Written as Levalbuterol
- COPD Assessment and Management Bundle Versus Usual CareCompletedNot applicableUniversity of Illinois at ChicagoNCT01833026Written as Levalbuterol
- Trough Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolCompletedPhase 4University of DundeeNCT00831376Written as levosalbutamol
- Effect of Nebulized Bronchodilators on Heart RateCompletedPhase 4Fahim Khorfan, MDNCT01151579Written as Levalbuterol
- Aerosolized Beta-Agonist Isomers in AsthmaCompletedPhase 4Duke UniversityNCT02170532Written as levalbuterol
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaCompletedPhase 3Sumitomo Pharma America, Inc.NCT00809757Written as Levalbuterol
- Continuous Levalbuterol for Treatment of Status Asthmaticus in ChildrenCompletedPhase 4Children's Hospital of PhiladelphiaNCT00124176Written as Levalbuterol (R albuterol)
- A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedPhase 2Sumitomo Pharma America, Inc.NCT01656811Written as levalbuterol 90 mcg
- Peak Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolWithdrawnPhase 4University of DundeeNCT00830882Written as levosalbutamol
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedPhase 3Sumitomo Pharma America, Inc.NCT00073840Written as levalbuterol
- Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaCompletedPhase 3Sumitomo Pharma America, Inc.NCT00667407Written as Levalbuterol 1.25 mg
- Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedPhase 4Sumitomo Pharma America, Inc.NCT00667797Written as levalbuterol HCl
- A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric SubjectsCompletedPhase 2Sumitomo Pharma America, Inc.NCT00583947Written as levalbuterol
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)CompletedPhase 2Astion Pharma A/SNCT00625157Written as ASF 1096 0.5 % cream
- Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) LesionsCompletedPhase 2Astion Pharma A/SNCT00625521Written as ASF 1096 0.5 % cream applied twice daily
See all 21 studies that test Levalbuterol →
Given in every arm · 4 — Levalbuterol is usual care beside what is tested
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaCompletedPhase 3SanofiNCT02528214Written as Levalbuterol/Levosalbutamol
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)CompletedPhase 3SanofiNCT02414854Written as Levalbuterol/Levosalbutamol
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaCompletedPhase 2SanofiNCT01854047Written as Levosalbutamol/levalbuterol
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedPhase 2SanofiNCT01312961Written as Levalbuterol
As the comparator · 1 — what is tested is compared with Levalbuterol
Codes
What other systems call Levalbuterol · ClinicalTrials.gg INT008963
- MeSH (NLM) D064412LevalbuterolConfirmed NLM, Wikidata
- UNII (FDA) EDN2NBH5SSLEVALBUTEROLConfirmed FDA, NLM, Wikidata
- RxNorm 237159Confirmed FDA, Wikidata
- Wikidata Q408709levalbuterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74196LevalbuterolOne source FDA
- DrugBank DB13139One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064412 | Levalbuterol | Confirmed NLM, Wikidata |
| UNII (FDA) | EDN2NBH5SS | LEVALBUTEROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 237159 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408709 | levalbuterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74196 | Levalbuterol | One source FDA |
| DrugBank | DB13139 | — | One source Wikidata |
Also registered as levalbuterol hydrochloride (UNII WDQ1526QJM · RxNorm 237160).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.